Resveratrol - CAS 501-36-0
Resveratrol (CAS 501-36-0) is a phytoalexin derived from grapes and other food products with antioxidant and potential chemopreventive activities. Resveratrol induces phase II drug-metabolizing enzymes (anti-initiation activity); mediates anti-inflammatory effects and inhibits cyclooxygenase and hydroperoxidase functions (anti-promotion activity); and induces promyelocytic leukemia cell differentiation (anti-progression activity), thereby exhibiting activities in three major steps of carcinogenesis. This agent may inhibit TNF-induced activation of NF-kappaB in a dose- and time-dependent manner.
* For research use only. Not for human or veterinary use.
|Solubility||>9.7mg/mL in DMSO|
|Overview of Clinical Research||<span style="color:#000000;"><span style="font-family:arial,helvetica,sans-serif;"><span style="font-size:12px;">Resveratrol is an a<span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">ntioxidant and a ribonucleotide reductase inhibitor as well as a SIRT1 protein stimulant. It has been granted for its orphan drug status in MELAS syndrome.</span></span></span></span>|